期刊文献+

磺脲类药物在治疗2型糖尿病过程中的安全性 被引量:4

The Security Overview of Sulfonylurea in the Treatment of Type 2 Diabetes During
暂未订购
导出
摘要 随着医疗水平和医药产业的发展,降糖药的应用对糖尿病的治疗起到了极大的促进作用,但同时药物引发的不良反应及合理用药也成为了糖尿病治疗过程中需要关注的现实问题。本文对磺脲类降糖药的安全性进行了初步阐述,旨在为临床合理用药提供参考。 With the development of medical standards and pharmaceutical industries,the application of hypoglycemic agents has played a significant role in the treatment of diabetes,but at the same time,drug-induced adverse reactions and rational use of drugs during the treatment of diabetes has also become to be the practical problems.In this paper,through a preliminary dissertation on the safety of sulfonylureas hypoglycemic agents,The purpose is to provide a reference of clinical rational use of drugs.
出处 《中国药物警戒》 2010年第5期298-300,共3页 Chinese Journal of Pharmacovigilance
关键词 磺脲类药物 2型糖尿病 安全性 Sulfonylurea type 2 diabetes Security
  • 相关文献

参考文献3

二级参考文献20

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7滕彩华,刘翠英,陈健仁,等.糖尿病的口服降糖药物治疗.见:邓尚平主编.临床糖尿病学.第1版.成都:四川科学技术出版社,2000.109-115.
  • 8Inagaki N, Gonoi T, Clement JP 4th, et al. Reconstitution of KATP: An inward rectifier- subunit plus the sulfonylurea receptor. Science,1995,270:1166-1170.
  • 9Dorschner H, Brakardin E, Uhde I, et al. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Molecular Pharmacology,1999,55:1060-1066.
  • 10O′Rourke B. Myocardial KATP channels in preconditioning. Circulation Research,2000,87:845-855.

共引文献870

同被引文献38

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部